Valproic acid teratogenesis and embryonic lipid metabolism.
D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D004622:Embryo, Mammalian / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008055:Lipids / Q000096:biosynthesis*; D008148:Lovastatin / Q000031:analogs & derivatives*; D009281:Naphthalenes / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D013723:Teratogens / Q000494:pharmacology; D014635:Valproic Acid / Q000494:pharmacology*
D002087:Butyrates; D008055:Lipids; D009281:Naphthalenes; D013723:Teratogens; D020148:Butyric Acid; D014635:Valproic Acid; C040295:mevinolinic acid; D008148:Lovastatin